Boston Scientific Estimate Lowered and 4 Stock Analyses Not to Ignore
Cepheid (NASDAQ:CPHD): Goldman stated that shares of Cepheid continue to be oversold after the analyst meeting and also stated that management failed to reveal any new incremental information. The firm...
View ArticleDollar General Continues to Expand and 4 Stock Analyses to Notice Today
Dollar General Corporation (NYSE:DG): Bank of America Merrill Lynch stated that Dollar General is still implementing retail invitations and expanding product assortment. The firm keeps expecting market...
View ArticleCepheid Wins FDA Clearance for Xpert CT/NG, TranS1 Settles with DOJ:...
On Friday, Mylan (NASDAQ:MYL) reported that its partner, Famy Care, won final approval from the FDA for its Abbreviated New Drug application for Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.15...
View ArticleCepheid Pullback Viewed as Overdone and 4 Stock Analyses to Know Now
Transocean Ltd. (NYSE:RIG): Current price $51.04 Wells Fargo viewed the settlement details between Transocean Ltd. and the Department of Justice as extremely positive for the company. Wells noted the...
View ArticleCepheid Under Pressure and 4 Stock Analyses Making Rounds
Polaris Industries, Inc. (NYSE:PII): Current price $92.80 RBC Capital thinks that Polaris Industries, Inc. can report slightly higher than expected fourth quarter earnings per share, but the firm...
View ArticleCepheid Earnings: Here’s Why Investors are Excited Now
Cepheid (NASDAQ:CPHD) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the...
View ArticleDid These Stocks Miss or Beat Analyst Expectations?
Chemed Corp. (NYSE:CHE) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased 14.05% to $1.38 in the quarter versus EPS of...
View ArticleTarget Executive Officer Sells More Than 41K Shares and 4 Insider Sales to Note
Schiel Tina M who is Executive Officer at Target Corp. (NYSE:TGT), sold 41,539 shares at $68.80 per share for a total value of $2,857,862. The shares recently traded at $69.69, up $0.89, or 1.29% since...
View ArticleCepheid Earnings: Everything You Must Know Now
Cepheid (NASDAQ:CPHD) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the...
View ArticleInvestors Ride 5 Earnings Rollercoaster Rides
Cepheid (NASDAQ:CPHD) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share decreased 0% to $0.02 in the quarter versus EPS of $0.02 in...
View Article
More Pages to Explore .....